Page 70 - Read Online
P. 70

Author Instructions

           2.3.3.5 Conflicts of Interest
           Authors  must  declare  any  potential  conflicts  of  interest  that  may  be  perceived  as  inappropriately  influencing  the
           representation or interpretation of reported research results. If there are no conflicts of interest, please state “All authors
           declared that there are no conflicts of interest.” in this section. Some authors may be bound by confidentiality agreements.
           In such cases, in place of itemized disclosures, we will require authors to state “All authors declare that they are bound by
           confidentiality agreements that prevent them from disclosing their conflicts of interest in this work.”. If authors are unsure
           whether conflicts of interest exist, please refer to the “Conflicts of Interest” of OAE Editorial Policies for a full explanation.
           2.3.3.6 Ethical Approval and Consent to Participate
           Research involving human subjects, human material or human data must be performed in accordance with the Declaration
           of Helsinki and approved by an appropriate ethics committee. An informed consent to participate in the study should also
           be obtained from participants, or their parents or legal guardians for children under 16. A statement detailing the name of
           the ethics committee (including the reference number where appropriate) and the informed consent obtained must appear
           in the manuscripts reporting such research.
           Studies involving animals and cell lines must include a statement on ethical approval. More information is available at
           Editorial Policies.
           If the manuscript does not involve such issue, please state “Not applicable.” in this section.

           2.3.3.7 Consent for Publication
           Manuscripts containing individual details, images or videos, must obtain consent for publication from that person, or in
           the case of children, their parents or legal guardians. If the person has died, consent for publication must be obtained from
           the next of kin of the participant. Manuscripts must include a statement that a written informed consent for publication was
           obtained. Authors do not have to submit such content accompanying the manuscript. However, these documents must be
           available if requested. If the manuscript does not involve this issue, state “Not applicable.” in this section.
           2.3.3.8 Copyright
           Authors retain copyright of their works through a Creative Commons Attribution 4.0 International License that clearly
           states how readers can copy, distribute, and use their attributed research, free of charge. A declaration “© The Author(s)
           2020.” will be added to each article. Authors are required to sign License to Publish before formal publication.

           2.3.3.9 References
           References should be numbered in order of appearance at the end of manuscripts. In the text, reference numbers should
           be placed in square brackets and the corresponding references are cited thereafter. Only the first five authors’ names are
           required to be listed in the references, other authors’ names should be omitted and replaced with “et al.”. Abbreviations of
           the journals should be provided on the basis of Index Medicus. Information from manuscripts accepted but not published
           should be cited in the text as “Unpublished material” with written permission from the source.
           References should be described as follows, depending on the types of works:
            Types                Examples
            Journal articles by   Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, et al. Effect of occult metastases on
            individual authors   survival in node-negative breast cancer. N Engl J Med 2011;364:412-21. [PMID: 21247310 DOI:
                                 10.1056/NEJMoa1008108]
            Organization as author  Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants
                                 with impaired glucose tolerance. Hypertension 2002;40:679-86. [PMID: 12411462]
            Both personal authors and  Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction
            organization as author  in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003;169:2257-61. [PMID:
                                 12771764 DOI: 10.1097/01.ju.0000067940.76090.73]
            Journal articles not in   Zhang X, Xiong H, Ji TY, Zhang YH, Wang Y. Case report of anti-N-methyl-D-aspartate receptor
            English              encephalitis in child. J Appl Clin Pediatr 2012;27:1903-7. (in Chinese)
            Journal articles ahead of   Odibo AO. Falling stillbirth and neonatal mortality rates in twin gestation: not a reason for
            print                complacency. BJOG 2018; Epub ahead of print [PMID: 30461178 DOI: 10.1111/1471-0528.15541]
            Books                Sherlock S, Dooley J. Diseases of the liver and billiary system. 9th ed. Oxford: Blackwell Sci Pub;
                                 1993. pp. 258-96.
            Book chapters        Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein
                                 B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. pp. 93-
                                 113.
            Online resource      FDA News Release. FDA approval brings first gene therapy to the United States. Available from:
                                 https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574058.htm. [Last accessed
                                 on 30 Oct 2017]
   65   66   67   68   69   70   71   72   73